Interleukin 6 News and Research

RSS
Interleukin-6 (IL-6) is a protein that in humans is encoded by the "IL6" gene. IL-6 is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. It is secreted by T cells and macrophages to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation.
Giving social support to others may play an important role in health

Giving social support to others may play an important role in health

Paper-based innovations for COVID-19 diagnosis

Paper-based innovations for COVID-19 diagnosis

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Scientists identify new gene that contributes to type 1 diabetes progression

Scientists identify new gene that contributes to type 1 diabetes progression

SARS-CoV-2 infection inhibited by CCR2 signaling

SARS-CoV-2 infection inhibited by CCR2 signaling

The case for vaccinating children under 12 against COVID-19

The case for vaccinating children under 12 against COVID-19

Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection

Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection

Inflammatory cytokines may help predict patient outcomes after traumatic injury

Inflammatory cytokines may help predict patient outcomes after traumatic injury

Impact of SARS-CoV-2 infection on human semen quality

Impact of SARS-CoV-2 infection on human semen quality

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Biomarker predicts severity of SARS-CoV-2 infection in patients

Biomarker predicts severity of SARS-CoV-2 infection in patients

Key lessons from COVID-19 pandemic for scientific and clinical communities

Key lessons from COVID-19 pandemic for scientific and clinical communities

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

WHO experts recommend antibody treatment for two specific groups of patients with covid-19

WHO experts recommend antibody treatment for two specific groups of patients with covid-19

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Deep profiling of SARS-CoV-2 immune response amongst the mildly symptomatic

Deep profiling of SARS-CoV-2 immune response amongst the mildly symptomatic

Flu shots and COVID-19 immunity

Flu shots and COVID-19 immunity